Arcus Biosciences, Inc. announced that Jennifer Jarrett will step down as the company's Chief Financial and Operating Officer, effective January 11, 2019, to pursue an opportunity at a privately-held transportation and technology company. Ms. Jarrett will remain actively engaged with the company and has been appointed to company's Board of Directors commencing January 12, 2019.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.72 USD | +1.91% |
|
+11.79% | -17.59% |
09/07 | Arcus Biosciences Says Taiho Has Exercised Option for Exclusive License to Quemliclustat in Japan | MT |
05/07 | Sector Update: Health Care Stocks Advance in Afternoon Trading | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.59% | 140.25Cr | |
+24.74% | 4.66TCr | |
+45.38% | 4.17TCr | |
+0.17% | 4.12TCr | |
+33.19% | 3.24TCr | |
+21.06% | 2.82TCr | |
-6.35% | 2.81TCr | |
+48.93% | 1.45TCr | |
+47.23% | 1.37TCr | |
+3.24% | 1.22TCr |
- Stock Market
- Equities
- RCUS Stock
- News Arcus Biosciences, Inc.
- Arcus Biosciences, Inc. Announces Management Changes